- Home
- TTNP vs PRSO Comparison
TTNP vs PRSO Comparison
Compare TTNP & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- PRSO
- Stock Information
- Founded
- TTNP 1991
- PRSO 2008
- Country
- TTNP United States
- PRSO United States
- Employees
- TTNP N/A
- PRSO N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- PRSO Semiconductors
- Sector
- TTNP Health Care
- PRSO Technology
- Exchange
- TTNP Nasdaq
- PRSO Nasdaq
- Market Cap
- TTNP 3.0M
- PRSO 3.3M
- IPO Year
- TTNP 1996
- PRSO 2001
- Fundamental
- Price
- TTNP $3.67
- PRSO $0.94
- Analyst Decision
- TTNP
- PRSO Strong Buy
- Analyst Count
- TTNP 0
- PRSO 2
- Target Price
- TTNP N/A
- PRSO $3.38
- AVG Volume (30 Days)
- TTNP 25.0K
- PRSO 76.9K
- Earning Date
- TTNP 03-31-2025
- PRSO 03-17-2025
- Dividend Yield
- TTNP N/A
- PRSO N/A
- EPS Growth
- TTNP N/A
- PRSO N/A
- EPS
- TTNP N/A
- PRSO N/A
- Revenue
- TTNP N/A
- PRSO $12,728,000.00
- Revenue This Year
- TTNP N/A
- PRSO $9.59
- Revenue Next Year
- TTNP N/A
- PRSO $1.63
- P/E Ratio
- TTNP N/A
- PRSO N/A
- Revenue Growth
- TTNP N/A
- PRSO N/A
- 52 Week Low
- TTNP $3.03
- PRSO $0.73
- 52 Week High
- TTNP $14.80
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- TTNP 50.98
- PRSO 50.19
- Support Level
- TTNP $3.35
- PRSO $0.82
- Resistance Level
- TTNP $4.24
- PRSO $0.92
- Average True Range (ATR)
- TTNP 0.29
- PRSO 0.07
- MACD
- TTNP 0.02
- PRSO 0.02
- Stochastic Oscillator
- TTNP 46.73
- PRSO 60.38
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.